Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Palantir Technologies, Palo Alto, California, USA.
Br J Surg. 2021 Jan 27;108(1):e24-e26. doi: 10.1093/bjs/znaa062.
This research letter details the experience of a large cancer center's experience with a universal asymptomatic preoperative SARS-CoV-2 testing program that facilitated safe surgical treatment during a local surge of coronavirus cases. A total of 5,234 asymptomatic tests were performed with a test positivity rate that correlated with the increase in community prevalence of COVID-19 infections. No patients developed a postoperative SARS-CoV-2 infection with no documented patient-to-patient or patient-to-provider spread.
这封研究信函详细介绍了一家大型癌症中心在当地冠状病毒病例激增期间实施通用无症状术前 SARS-CoV-2 检测计划的经验。共进行了 5234 例无症状检测，检测阳性率与社区 COVID-19 感染流行率的增加相关。没有患者发生术后 SARS-CoV-2 感染，也没有记录到患者之间或患者与医务人员之间的传播。
